$RLFTF

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Reports 2020 Financial Results and Provides Business Update 3 days, 14 hours ago

$RLFTF

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Engages Jan-Jaap Scherpbier of Sonsbeek Pharma Consultancy B.V. as Manufacturing and Supply Chain Consultant 1 week, 4 days ago

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored Global Clinical Trial to Include Aviptadil and Remdesivir 1 week, 5 days ago

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Confirms Release of 60-Day Findings from Phase 2b/3 Clinical Trial of Intravenous RLF-100(TM) (aviptadil) 2 weeks, 4 days ago

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 Clinical Trial and Also Demonstrated a Meaningful Benefit in Survival from Critical COVID-19 2 weeks, 6 days ago

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | Relief Increases Issued Share Capital with Creation of Treasury Shares 1 month, 1 week ago

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | NeuroRx Announced that RLF-100(TM) has Demonstrated Ten-Day Accelerated Recovery from Respiratory Failure among Patients with Severe Covid-19 Treated with HFNO at 28 Day Interim Endpoint 1 month, 3 weeks ago

Robot wrote a new post, $RLFTF #OTCQB RELIEF THERAPEUTICS HLDG AG (RLFTF: OTCQB) | NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint 1 month, 3 weeks ago